Abstract QS22: Defining Enhanced Recovery Pathway With Or Without Liposomal Bupivacaine In Diep Flap Breast Reconstruction
Main Authors: | Ricardo Garza, Jr., B.S., Carolyn E. Boyle, MSN, CRNA, Yulun Liu, PhD, Yash Kadakia, B.A., Julie L. Cooper, B.S., Sami U. Khan, MD, Nicholas T. Haddock, MD, Sumeet S. Teotia, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-04-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/01.GOX.0000667944.75272.a8 |
Similar Items
-
Abstract QS14: Abdominal Weakness, Bulge Or Hernia After DIEP Flaps: An Algorithm Of Management, Prevention, And Surgical Repair With Classification
by: Abby Warren, MD, et al.
Published: (2020-04-01) -
QS21. Surgical Outcomes of Autologous Breast Reconstruction in Low BMI Patients; Beyond the Gold Standard DIEP Flap
by: Valeria Mejia Martinez, BS, et al.
Published: (2022-06-01) -
Abstract 67: Patient Selection For DIEP Flap Breast Reconstruction In The Obese Population: Stratifying Surgical Risk Factors For Patient Inclusion Or Exclusion
by: Avinash P. Jayaraman, BA, et al.
Published: (2020-04-01) -
Abstract 76: Implications Of Instituting An Eras Pathway In Patients Receiving Chemotherapy In Microsurgical Breast Reconstruction
by: Ricardo Garza, Jr., BS, et al.
Published: (2020-04-01) -
P44. OPERATIVE TIME IS AN INDEPENDENT PREDICTOR OF ADVERSE POSTOPERATIVE OUTCOMES IN DIEP FLAP BREAST RECONSTRUCTION: A MULTIVARIATE ANALYSIS OF 1000 BILATERAL FLAPS
by: Nicholas T. Haddock, MD, et al.
Published: (2022-04-01)